Nick Chu
Optometrist · Cedar Park, TXNPI 1518255538
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 75.2% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $5,166, 9.1 times the $571 reported in 2019. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $181.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$13K
- Johnson & Johnson Vision Care, Inc.$2K
- Bausch & Lomb Americas Inc.$539
- Alcon$394
- Bausch & Lomb, A Division Of Bausch Health US, LLC$338
- AbbVie$283
- plus $589 from 10 others
What the payments were for
- Consulting fees$4,40525%
- Speaking & faculty fees$7,02540%
- Travel & lodging$3,05617%
- Food & beverage$3,12718%
- Entertainment$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 25 | $13,276 |
| Johnson & Johnson Vision Care, Inc. | 16 | $2,233 |
| Bausch & Lomb Americas Inc. | 14 | $539 |
| Alcon | 10 | $394 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $338 |
| AbbVie(2 entities) | 5 | $283 |
| Optos, Inc. | 3 | $177 |
| Visioneering Technologies, Inc. | 2 | $100 |
| Biotissue Holdings Inc. | 3 | $88 |
| Shire North American Group Inc | 3 | $57 |
| Oyster Point Pharma, Inc. | 1 | $45 |
| Sight Sciences, Inc. | 2 | $39 |
| Novartis | 2 | $33 |
| Maculogix, Inc. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Kala Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$11,213
- Acuvue$1,905
- SynergEyes contact lens$1,750
- INFUSE$242
- BIOTRUE$125
- ULTRA$125
- BIOTRUE ONE DAY$125
- P200DTx$122
- P200T$122
- P200TE$122
- P200TxE$122
- DURYSTA$121
- ILUX$108
- VUITY$103
How this compares
$17,652 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 45 | $750 |
| Timolol Maleate | 12 | $169 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Cedar Park
- Oliver LouCedar Park$80K
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Emile FadelAustin$225K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
- Jill AutryBellaire$171K
- Stacie VirdenWaco$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.